Brian Ferrier
Chief Executive Officer chez Howell Biopharma Ltd.
Profil
Brian Ferrier is currently the President, Chief Executive Officer & Director at Howell Biopharma Ltd.
He is also an Independent Director at Nukkleus, Inc. (New Jersey) and Nukkleus, Inc. Mr. Ferrier was previously an Independent Director at Brilliant Acquisition Corp.
He received his undergraduate degree and MBA from York University.
Postes actifs de Brian Ferrier
| Sociétés | Poste | Début |
|---|---|---|
| Howell Biopharma Ltd. | Chief Executive Officer | 01/01/2017 |
Nukkleus, Inc. (New Jersey)
 Nukkleus, Inc. (New Jersey) Financial ConglomeratesFinance Nukkleus, Inc. engages in the provision of software and technology solutions for the retail foreign exchange trading industry. The firm operates through the General Support Services and Financial Services segments. The General Support Services segment provides software, technology, customer sales and marketing and risk management technology hardware and software solutions. The Financial Services segment offers payment services from one fiat currency to another or to digital assets. The company was founded on July 29, 2013 and is headquartered in Jersey City, NJ. | Director/Board Member | - |
Anciens postes connus de Brian Ferrier
| Sociétés | Poste | Fin |
|---|---|---|
| BRIT ACQU | Director/Board Member | - |
Formation de Brian Ferrier
| York University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Nukkleus, Inc. (New Jersey)
Nukkleus, Inc. (New Jersey) Financial ConglomeratesFinance Nukkleus, Inc. engages in the provision of software and technology solutions for the retail foreign exchange trading industry. The firm operates through the General Support Services and Financial Services segments. The General Support Services segment provides software, technology, customer sales and marketing and risk management technology hardware and software solutions. The Financial Services segment offers payment services from one fiat currency to another or to digital assets. The company was founded on July 29, 2013 and is headquartered in Jersey City, NJ. | Finance |
| Howell Biopharma Ltd. | |
Brilliant Acquisition Corp.
 Brilliant Acquisition Corp. Financial ConglomeratesFinance Brilliant Acquisition Corp. is a blank check company. It engages in effecting a merger, share exchange, asset acquisition, or other similar business combination with one or more businesses or entities. The company was founded in 2019 and is headquartered in Shanghai, China. | Finance |
